Senate Subcommittee Investigates Corruption in Vaccine Safety Data and Agency Integrity
September 04, 2025 | Finance: Senate Committee, Standing Committees - House & Senate, Congressional Hearings Compilation
This article was created by AI summarizing key points discussed. AI makes mistakes, so for full details and context, please refer to the video of the full meeting. Please report any errors so we can fix them. Report an error »
The US Senate Committee on Finance convened on September 4, 2025, to discuss critical aspects of President Biden's 2026 Health Care Agenda, focusing particularly on vaccine safety and the integrity of scientific research. The meeting featured a heated exchange regarding the alleged corruption of scientific data related to COVID-19 vaccines and other health interventions.
The session began with a presentation on the findings from the Vaccine Adverse Event Reporting System (VAERS), which reported 38,742 deaths associated with COVID-19 vaccinations. A committee member emphasized that 9,252 of these deaths occurred on the day of vaccination or within two days, raising concerns about the reliability of the data and the transparency of health agencies. The member criticized the Biden administration for what they described as censorship surrounding discussions of vaccine safety, claiming that dissenting voices have faced deplatforming.
The committee also announced plans for a forthcoming hearing to examine a study comparing vaccinated and unvaccinated populations. This study, which has not yet been released, reportedly indicates that vaccinated individuals may be more prone to chronic illnesses than those who have not received vaccines. The member expressed frustration over the delay in publishing this study, suggesting that it reflects broader issues of scientific integrity.
Further discussions highlighted allegations of data manipulation within the Centers for Disease Control and Prevention (CDC). A specific case was cited involving an internal study that purportedly showed a higher risk of autism diagnoses among black boys who received the MMR vaccine on time. The member claimed that the data was ordered to be destroyed by CDC officials before the study was published, raising serious questions about the credibility of health agencies.
The meeting concluded with a brief recess, during which committee members prepared for further questioning and discussions. The overarching theme of the session was a call for greater accountability and transparency in health research, particularly regarding vaccine safety and the influence of pharmaceutical companies on public health policy. The committee aims to address these issues in future hearings and discussions as part of the ongoing health care agenda.
The session began with a presentation on the findings from the Vaccine Adverse Event Reporting System (VAERS), which reported 38,742 deaths associated with COVID-19 vaccinations. A committee member emphasized that 9,252 of these deaths occurred on the day of vaccination or within two days, raising concerns about the reliability of the data and the transparency of health agencies. The member criticized the Biden administration for what they described as censorship surrounding discussions of vaccine safety, claiming that dissenting voices have faced deplatforming.
The committee also announced plans for a forthcoming hearing to examine a study comparing vaccinated and unvaccinated populations. This study, which has not yet been released, reportedly indicates that vaccinated individuals may be more prone to chronic illnesses than those who have not received vaccines. The member expressed frustration over the delay in publishing this study, suggesting that it reflects broader issues of scientific integrity.
Further discussions highlighted allegations of data manipulation within the Centers for Disease Control and Prevention (CDC). A specific case was cited involving an internal study that purportedly showed a higher risk of autism diagnoses among black boys who received the MMR vaccine on time. The member claimed that the data was ordered to be destroyed by CDC officials before the study was published, raising serious questions about the credibility of health agencies.
The meeting concluded with a brief recess, during which committee members prepared for further questioning and discussions. The overarching theme of the session was a call for greater accountability and transparency in health research, particularly regarding vaccine safety and the influence of pharmaceutical companies on public health policy. The committee aims to address these issues in future hearings and discussions as part of the ongoing health care agenda.
View full meeting
This article is based on a recent meeting—watch the full video and explore the complete transcript for deeper insights into the discussion.
View full meeting